Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors

Major Program(s) or Research Group(s)

  • Community Oncology and Prevention Trials
  • NCI Community Oncology Research Program
  • Supportive Care and Symptom Management

Sponsor

Wake Forest University Health Sciences

Status

Enrolling by invitation

ClinicalTrials.gov ID

For more information, see ClinicalTrials.gov NCT03935282

The objective of this hybrid effectiveness-implementation study is to examine the effects of
an EHR-based cardiovascular health assessment tool (AH-HA) among breast, prostate,
colorectal, endometrial, and Hodgkin and non-Hodgkin lymphoma cancer survivors (N=600)
receiving survivorship care in community oncology practices, using a group-randomized trial
design (6 intervention practices and 6 usual care practices). Our central hypothesis is that
the AH-HA tool will increase (1) cardiovascular health (CVH) discussions among survivors and
oncology providers, (2) referrals and visits to primary care and cardiology (care
coordination), and (3) cardiovascular (CV) risk reduction and health promotion activities
compared to usual care.

Intervention

AH-HA Tool in the EPIC EHR

Condition

Breast Neoplasm, Prostatic Neoplasm, Colorectal Neoplasms, Endometrial Neoplasms, Hodgkin Disease, Non Hodgkin Lymphoma

Investigators

Kathryn Weaver, MD

See list of participating sites